WST Financial Facts
Income tax expense: 14.4MResearch and development: 9M
See Full Income Statement
Notes payable and other current debt: 2.6M
Total current liabilities: 236.8M
See Full Balance Sheet
West Pharmaceutical Services, Inc. (WST) Earnings
|
Expand Research on WST
| Next EPS Date | 10/22/26 | EPS Growth Rate | +11.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.9% | Revenue Growth Rate | +2.5% |
| Average % Move 1-Wk after EPS | +1.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/26  |
Q326 | N/A | $2.19 | N/A | N/A | $824.6M | = | N/A | N/A | ||
| 7/23/26 | Q226 | $2.37 | $2.08 | +$0.29 | $872.3M | $839.75M | = |  | | Details | |
| 4/23/26 | Q126 | $2.13 | $1.68 | +$0.45 | $844.9M | $780.65M | = | | | Details | |
| 2/12/26 | Q425 | $2.04 | $1.84 | +$0.20 | $805M | $796.25M | = | | | Details | |
| 10/23/25 | Q325 | $1.96 | $1.69 | +$0.27 | $804.6M | $786.33M | = | | | Details | |
| 7/24/25 | Q225 | $1.84 | $1.51 | +$0.33 | $766.5M | $725.26M | = | | | Details | |
| 4/24/25 | Q125 | $1.45 | $1.23 | +$0.22 | $698M | $684.94M | = | | | Details | |
| 2/13/25 | Q424 | $1.82 | $1.72 | +$0.10 | $748.8M | $740.75M | = | | | Details |
